In a report released on August 28, Kate McShane from Goldman Sachs maintained a Buy rating on Petco Health and Wellness Company, with a price target of $5.14.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kate McShane’s rating is based on Petco Health and Wellness Company’s better-than-expected adjusted earnings per share for the second quarter of 2025, which came in at $0.07, surpassing both Goldman Sachs and consensus estimates. Despite a slight decline in net revenue and comparable sales, the company’s adjusted EBITDA exceeded expectations, indicating strong operational performance.
Moreover, the management’s decision to raise the full-year earnings outlook, particularly the adjusted EBITDA forecast, reflects confidence in the company’s future financial performance. This positive outlook, alongside the introduction of guidance for the third quarter, supports the Buy rating as it suggests potential for continued growth and profitability in the upcoming quarters.
In another report released on August 29, RBC Capital also maintained a Buy rating on the stock with a $4.00 price target.
WOOF’s price has also changed moderately for the past six months – from $2.690 to $3.230, which is a 20.07% increase.